(Q43860234)

27 November 2017

Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients (English)

1 reference

27 November 2017

1 reference

Neelke C van der Weerd

1

1 reference

27 November 2017

Muriel P C Grooteman

2

1 reference

27 November 2017

Michiel L Bots

3

1 reference

27 November 2017

Marinus A van den Dorpel

4

1 reference

27 November 2017

Claire H den Hoedt

5

1 reference

27 November 2017

Albert H A Mazairac

6

1 reference

27 November 2017

Menso J Nubé

7

1 reference

27 November 2017

E Lars Penne

8

1 reference

27 November 2017

Jack F M Wetzels

9

1 reference

27 November 2017

Erwin T Wiegerinck

10

1 reference

27 November 2017

Dorine W Swinkels

11

1 reference

27 November 2017

Peter J Blankestijn

12

1 reference

27 November 2017

Piet M Ter Wee

13

1 reference

27 November 2017

CONTRAST Investigators

14

1 reference

27 November 2017

language of work or name

English

0 references

publication date

11 November 2012

1 reference

Nephrology Dialysis Transplantation

27 November 2017

1 reference

27 November 2017

28

1 reference

27 November 2017

12

1 reference

27 November 2017

3062-3071

1 reference

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

27 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Iron supplementation to treat anemia in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Hepcidin in human iron disorders: diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Reduction of serum hepcidin by hemodialysis in pediatric and adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Iron in arterial plaque: modifiable risk factor for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Macrophage iron, hepcidin, and atherosclerotic plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Lost without directions: lessons from the anemia debate and the drive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Serum hepcidin: reference ranges and biochemical correlates in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

Serum Hepcidin and Macrophage Iron Correlate With MCP-1 Release and Vascular Damage in Patients With Metabolic Syndrome Alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS488

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS488

1 reference

27 November 2017

1 reference